Literature DB >> 22607565

High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan.

Minako Wakasugi1, Kazuko Kawamura, Suguru Yamamoto, Junichiro James Kazama, Ichiei Narita.   

Abstract

Infectious disease is the second leading cause of death among dialysis patients, and it is generally assumed that the mortality rate of infectious disease is considerably higher in dialysis patients than in the general population. There are no comprehensive studies on this issue and on the contribution of each category of infectious disease to excess mortality in dialysis patients in Japan. We used mortality data reported to the Japanese Society for Dialysis Therapy and national Vital Statistics data for 2008 and 2009. We calculated standardized mortality ratios and compared the mortality rates for each category of infectious disease. During the 2-year study period, 274,683 and 10,435 deaths from infectious diseases were recorded in 126 million people and 273,237 dialysis patients, respectively. The standardized mortality ratio for all infectious diseases was 7.5 (95% confidence interval, 7.3-7.6) in dialysis patients with respect to the general population in Japan. The categories of infectious disease with a significantly higher standardized mortality ratio among the dialysis patients were sepsis, peritonitis, influenza, tuberculosis, and pneumonia and in that order. In particular, the mortality rate of sepsis contributed to 69.5% of the difference in infectious disease mortality between dialysis patients and the general population. This study underlines markedly increased mortality from infectious diseases, particularly from sepsis, in dialysis patients compared with the general population.
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.

Entities:  

Mesh:

Year:  2012        PMID: 22607565     DOI: 10.1111/j.1744-9987.2012.01062.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  18 in total

1.  A case of disseminated tuberculosis after the initiation of hemodialysis.

Authors:  Jumpei Hasegawa; Sachiko Wakai
Journal:  CEN Case Rep       Date:  2013-04-10

2.  Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995-2014.

Authors:  Minako Wakasugi; Junichiro James Kazama; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2017-05-06       Impact factor: 2.801

Review 3.  Influenza and the patient with end-stage renal disease.

Authors:  Brendan T Bowman; Mitchell H Rosner
Journal:  J Nephrol       Date:  2017-05-20       Impact factor: 3.902

4.  Developing and validating a multivariable prediction model for in-hospital mortality of pneumonia with advanced chronic kidney disease patients: a retrospective analysis using a nationwide database in Japan.

Authors:  Daisuke Takada; Susumu Kunisawa; Takeshi Matsubara; Kiyohide Fushimi; Motoko Yanagita; Yuichi Imanaka
Journal:  Clin Exp Nephrol       Date:  2020-04-15       Impact factor: 2.801

5.  Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Authors:  L Huang; A W Langerak; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2016-08-19       Impact factor: 4.330

Review 6.  Noncardiovascular mortality in CKD: an epidemiological perspective.

Authors:  Dinanda J de Jager; Marc G Vervloet; Friedo W Dekker
Journal:  Nat Rev Nephrol       Date:  2014-02-04       Impact factor: 28.314

7.  Reducing the risk of infection in end-stage kidney failure patients treated by dialysis.

Authors:  Sophie Collier; Andrew Davenport
Journal:  Nephrol Dial Transplant       Date:  2014-10-08       Impact factor: 5.992

Review 8.  Bacteremia in hemodialysis patients.

Authors:  Masashi Suzuki; Nobuhiko Satoh; Motonobu Nakamura; Shoko Horita; George Seki; Kyoji Moriya
Journal:  World J Nephrol       Date:  2016-11-06

9.  Rate of bacteremia in the hemodialysis patient presenting to the emergency department with fever: a retrospective chart review.

Authors:  Nicholas Villalon; Neda Farzan; Kathryn Freeman
Journal:  Int J Emerg Med       Date:  2018-05-25

Review 10.  FGF23 in Acute and Chronic Illness.

Authors:  Christian Schnedl; Astrid Fahrleitner-Pammer; Peter Pietschmann; Karin Amrein
Journal:  Dis Markers       Date:  2015-09-28       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.